¼¼°èÀÇ ¸» ÇコÄÉ¾î ½ÃÀå
Equine Healthcare
»óǰÄÚµå : 1774813
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 501 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¸» ÇコÄÉ¾î ½ÃÀåÀº 2030³â±îÁö 108¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 71¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸» ÇコÄÉ¾î ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 7.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 108¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¹é½ÅÀº CAGR 8.9%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 34¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀǾàǰ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 6.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸» ÇコÄÉ¾î ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 23¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.6%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.5%¿Í 7.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.8%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¸» ÇコÄÉ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸» ÇコÄɾ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

¸» ÇコÄÉ¾î ½ÃÀåÀº ¸»ÀÇ ÁÖÀΰú Á¶·Ã»ç°¡ ¿¹¹æ °ü¸®, °í±Þ Áø´Ü, ¼º´É ÃÖÀûÈ­¸¦ Áß½ÃÇÔ¿¡ µû¶ó È®´ëµÇ°í ÀÖ½À´Ï´Ù. Àç»ý ¿ä¹ý, ¸» ¹é½Å, ¿µ»ó Áø´Ü µî ¼öÀÇÇÐÀÇ ¹ßÀüÀº ¸»ÀÇ °Ç°­À» °³¼±ÇÏ°í °æ±â °æ·ÂÀ» ¿¬ÀåÇϰí ÀÖ½À´Ï´Ù. Àμö°øÅëÀü¿°º´°ú ¸» Àü¿°º´¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿¹¹æÁ¢Á¾, ±¸Ãæ Ä¡·á, ¹ÙÀÌ¿À º¸¾È ´ëÃ¥¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á¿Í AI¸¦ Ȱ¿ëÇÑ Áø´ÜÀ» ÅëÇØ ¼öÀÇÇÐÀº ´õ¿í Ä£¼÷ÇØÁ³°í, ¿ø°Ý ¸ð´ÏÅ͸µ°ú Áúº´ Á¶±â ¹ß°ßÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. À¯ÀüÇÐÀû °Ë»ç´Â ¸»ÀÇ ¹ø½Ä ÇÁ·Î±×·¥¿¡¼­µµ ³Î¸® º¸±ÞµÇ¾î ¹ø½Ä¾÷ÀÚµéÀÌ À¯ÀüÀû Áúº´À» ½Äº°ÇÏ°í ¼±ÅÃÀû ¹ø½Ä Àü·«À» ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ½Â¸¶ °æ±âÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó, ¸»ÀÇ Àü¹®Àû °Ç°­°ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¸» »ê¾÷ÀÇ Çõ½ÅÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¸»ÀÇ °Ç°­ °ü¸®¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¸»¿ë ¿þ¾î·¯ºí °Ç°­ ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ Ã¤ÅÃÀº ¸»ÀÇ °Ç°­°ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¸»ÀÇ ÇãÅÍ, ¾ÈÀå, ·¹±× ·¦¿¡ ³»ÀåµÈ ½º¸¶Æ® ¼¾¼­´Â Ȱ·Â ¡Èĸ¦ ÃßÀûÇϰí, ÆÄÇàÀÇ Â¡Èĸ¦ °¨ÁöÇϰí, ¼öºÐÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¸ç, AI ±â¹Ý ºÐ¼®Àº ¼öÀǻ簡 °Ç°­ Ãß¼¼¸¦ ÆÄ¾ÇÇϰí, ÀáÀçÀû ºÎ»óÀ» ¿¹ÃøÇϰí, Ä¡·á °èȹÀ» ¸ÂÃãÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Áٱ⼼Æ÷ Ä¡·á¿Í ´ÙÇ÷¼ÒÆÇ Ç÷Àå(PRP) Ä¡·á¿Í °°Àº Àç»ýÀÇ·á ±â¼úÀº °æÁÖ¸¶ÀÇ ±Ù°ñ°Ý°è ¼Õ»óÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ°í ÀÖÀ¸¸ç, MRI¿Í CT ½ºÄµ°ú °°Àº ÷´Ü Áø´Ü µµ±¸´Â ÆÄÇàÀÇ ¹ß°ß°ú ü³» °Ç°­ »óÅ Æò°¡ÀÇ Á¤È®µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¸» ÀÇÇÐ ¿¬±¸°¡ ¹ßÀüÇÔ¿¡ µû¶ó °³ÀÎÈ­µÈ µ¥ÀÌÅÍ ±â¹Ý ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ ´Ã¾î³¯ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸» ÇコÄÉ¾î ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¸» ÇコÄÉ¾î ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½Â¸¶ °æ±â Âü¿©ÀÚ Áõ°¡, ¼öÀÇÇÐ ±â¼úÀÇ ¹ßÀü, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ÀÔ´Ï´Ù. ƯÈ÷ Àü¹® ¸¶ÁÖµé »çÀÌ¿¡¼­ Àü¿ë º¸ÃæÁ¦, ¼º´É Çâ»ó ¿ä¹ý, ¿µ»ó Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

AI, ¿ø°Ý ÀÇ·á, ¿þ¾î·¯ºí °Ç°­ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀº ¼öÀÇÇÐ Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϰí Áúº´ °ü¸®¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸»ÀÇ °Ç°­ ±âÁذú ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥À» °­È­Çϱâ À§ÇÑ ±ÔÁ¦ ³ë·ÂÀº ½ÃÀå ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ½Â¸¶ »ê¾÷ÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó Áø´Ü, Ä¡·á ¹× Áúº´ ¿¹¹æÀÇ Çõ½ÅÀÌ ÁÖµµÇÏ´Â ¸» °Ç°­ °ü¸® ½ÃÀåÀº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¹é½Å, ÀǾàǰ, »ç·á÷°¡¹°, »ý¹°ÇÐÀû Á¦Á¦, Áø´Ü ¾à, ¼ÒÇÁÆ®¿þ¾î£¦¼­ºñ½º, ±âŸ), ÀûÀÀÁõ(±Ù°ñ°Ý°è Àå¾Ö, ±â»ýÃæ °¨¿°Áõ, ¸» Ç츣Æä½º ¹ÙÀÌ·¯½º, ¸» ¹ÙÀÌ·¯½º¼º µ¿¸Æ¿°, ¸»ÀÎÇ÷翣ÀÚ, ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º, ÆÄ»ódz, ±âŸ ÀûÀÀÁõ), Ȱµ¿(½ºÆ÷Ã÷/·¹À̽º, ·¹Å©¸®¿¡À̼Ç, ±âŸ Ȱµ¿), À¯Åë ä³Î(µ¿¹° º´¿ø£¦Å¬¸®´Ð, E-Commerce, ½Â¸¶ ½Ã¼³, ±âŸ ä³Î)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Equine Healthcare Market to Reach US$10.8 Billion by 2030

The global market for Equine Healthcare estimated at US$7.1 Billion in the year 2024, is expected to reach US$10.8 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 11.6% CAGR

The Equine Healthcare market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Equine Healthcare Market - Key Trends & Drivers Summarized

Why Is Equine Healthcare Gaining More Attention?

The equine healthcare market is expanding as horse owners and trainers place greater emphasis on preventive care, advanced diagnostics, and performance optimization. Advances in veterinary medicine, including regenerative therapies, equine vaccines, and diagnostic imaging, are improving horse health and extending their athletic careers. The increasing awareness of zoonotic diseases and equine epidemics is driving demand for vaccinations, deworming treatments, and biosecurity measures.

The use of telemedicine and AI-driven diagnostics is making veterinary care more accessible, allowing for remote monitoring and early disease detection. Genetic testing is also gaining traction in equine breeding programs, helping breeders identify hereditary diseases and optimize selective breeding strategies. As equestrian sports grow in popularity, the need for specialized healthcare solutions tailored to performance horses is driving innovation in the industry.

How Are Technological Innovations Transforming Equine Healthcare?

The adoption of wearable health monitoring devices for horses is revolutionizing equine healthcare. Smart sensors integrated into halters, saddles, and leg wraps can track vital signs, detect signs of lameness, and monitor hydration levels in real-time. AI-powered analytics are helping veterinarians identify health trends, predict potential injuries, and customize treatment plans.

Additionally, regenerative medicine techniques such as stem cell therapy and platelet-rich plasma (PRP) therapy are being used to treat musculoskeletal injuries in performance horses. Advanced diagnostic tools, including MRI and CT scans, are improving the accuracy of lameness detection and internal health assessments. As research in equine medicine continues to progress, the market is expected to witness increased adoption of personalized and data-driven healthcare solutions.

What Are the Key Factors Driving Growth in the Equine Healthcare Market?

The growth in the equine healthcare market is driven by rising equestrian participation, advancements in veterinary technology, and increasing awareness of preventive care. The demand for specialized supplements, performance-enhancing therapies, and diagnostic imaging solutions is growing, particularly among professional horse owners.

The integration of AI, telemedicine, and wearable health monitoring solutions is expanding access to veterinary care and improving disease management. Additionally, regulatory efforts to enforce equine health standards and vaccination programs are boosting market demand. As the equestrian industry continues to evolve, the equine healthcare market is expected to grow significantly, with innovations in diagnostics, treatment, and disease prevention leading the way.

SCOPE OF STUDY:

The report analyzes the Equine Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Others); Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications); Activity (Sports / Racing, Recreation, Other Activities); Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Other Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â